13.87% -0.8412

Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1163)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Vergleichen Sie NYXH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	6.0206	233.92M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	459.87	166.19B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	208.50	66.11B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	83.95	42.07B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	207.28	30.34B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	29.12	15.25B	17.28B	108.00M	391.00M	0.20

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Vergleichen Sie NYXH mit anderen Aktien

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire

Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com India

Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - menafn

HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire

HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World

Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull

Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks

Nyxoah Says FDA Issues Approvable Letter for Genio System - MarketScreener

FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView

FDA Clears Path Forward for Nyxoah's Revolutionary Sleep Apnea Treatment - Stock Titan

Stifel Nicolaus Has Lowered Expectations for Nyxoah (NASDAQ:NYXH) Stock Price - Defense World

Stifel cuts Nyxoah stock price target to $15, maintains Buy By Investing.com - Investing.com Canada

Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates - MSN

(NYXH) Investment Analysis - Stock Traders Daily

Stifel cuts Nyxoah stock price target to $15, maintains Buy - Investing.com

Nyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call Transcript - Insider Monkey

H.C. Wainwright maintains Buy on Nyxoah shares, $17 target - Investing.com

Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... By GuruFocus - Investing.com Canada

Nyxoah Reports 2024 Financial Results and U.S. Launch Plans - TipRanks

Nyxoah Sa’s Earnings Call: Efficacy and Expansion - TipRanks

Nyxoah Reports Strong Q4 Growth as Sleep Apnea Device Nears FDA Green Light - Stock Titan

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - The Manila Times

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - The Manila Times

Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World

Nyxoah (NYXH) to Release Quarterly Earnings on Thursday - Defense World

Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz

(NYXH) Investment Report - news.stocktradersdaily.com

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - The Manila Times

Sleep Apnea Innovator Nyxoah Takes Center Stage at Major Healthcare Conference - StockTitan

Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday - Defense World

Nyxoah (NYXH) Projected to Post Earnings on Tuesday - MarketBeat

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) versus Nyxoah (NASDAQ:NYXH) Critical Review - Defense World

(NYXH) On The My Stocks Page - Stock Traders Daily

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewswire

Revolutionary Sleep Apnea Treatment Crosses Borders: Inside Genio's Middle East Launch - StockTitan

Nyxoah Launches Genio Therapy in Middle East with First UAE Implantation - TipRanks

Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat

Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World

Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert

(NYXH) Trading Report - Stock Traders Daily

Trend Tracker for (NYXH) - Stock Traders Daily

Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World

NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nyxoah Receives Transparency Notification from BlackRock - TipRanks

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH